GLP‑1 news from 1923
2 dated, sourced GLP-1 developments from 1923: approvals, trial results, prices, lawsuits, compounding and culture.
- Business
Novo Nordisk, maker of Ozempic and Wegovy, dates its founding to a 1923 insulin lab
Novo Nordisk lists December 21, 1923, as its founding date, when insulin production began in Denmark under the arrangement that became Nordisk Insulinlaboratorium. The company now makes Ozempic and Wegovy and reported revenue of 309.1 billion Danish kroner and net income of 102.4 billion kroner for 2025. Through Novo Holdings, the Novo Nordisk Foundation holds about 28.1% of shares and 77.1% of voting shares.
- Business
Lilly's 1923 launch of Iletin began a century of diabetes drugs
Eli Lilly and Company introduced Iletin in 1923, which the company describes as the world's first commercially available insulin product, for a disease that was then fatal. Insulin anchored Lilly's business for decades. Today tirzepatide (Mounjaro, Zepbound) accounts for 56% of the company's 2025 revenues.